BeiGene bags option on Leap cancer drug, requests PD-1 combination trial
BeiGene and Leap Therapeutics have teamed up to study a combination of an anti-DKK1 antibody with the anti-PD-1 antibody tislelizumab in patients... Read More
BeiGene bags option on Leap cancer drug, requests PD-1 combination trial
BeiGene and Leap Therapeutics have teamed up to study a combination of an anti-DKK1 antibody with the anti-PD-1 antibody tislelizumab in patients... Read More
Blueprint Medicines Announces FDA Approval of AYVAKIT™ (avapritinib) for the Treatment of Adults with Unresectable or Metastatic PDGFRA Exon 18 Mutant Gastrointestinal Stromal Tumor
Blueprint Medicines won FDA approval for Ayvakit (avapritinib), the first treatment for gastrointestinal stromal tumors (GISTs) that targets platelet-derived growth factor alpha... Read More
Phase II DESTINY-Gastric01 trial of Enhertu versus chemotherapy met primary endpoint
The new targeted drug Enhertu showed a promising response rate in a trial of patients with HER2-positive gastric cancer.
Light to moderate amount of lifetime alcohol consumption and risk of cancer in Japan
A Japanese study published in the journal Cancer reports that even moderate alcohol consumption raises the risk of cancer and that the... Read More
Gritstone posts ‘one of the most potent immunogenic-responses for a neoantigen vaccine’
Two patients with gastroesophageal cancer responded well to Gritstone Oncology’s immune-stimulating treatment in an early trial.
Cancer’s Addiction Could Be A Way to Defeat It
Researchers at the University of Melbourne created gastric cancer “organoids,” tiny replicas of diseased tissue, and used them to discover that a... Read More
Many younger patients with stomach cancer have a distinct disease, Mayo research discovers
Mayo Clinic researchers discovered that many people younger than 60 who develop gastric cancer have a genetically distinct form of the disease... Read More
Treatment Efficacy in Metastatic Esophageal, Gastric, or Gastroesophageal Cancer According to Expression of ERCC1
The biomarker ERCC1 is of interest for predicting sensitivity to platinum-based chemo, but a recent study in the Journal of Clinical Oncology... Read More
Gastric Cancer Foundation Funds Important New Stomach Cancer Research
The Gastric Cancer Foundation recently announced a new $75,000 research grant to The University of Texas MD Anderson Cancer Center. This funding... Read More